Home > Financial Ratios > SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Core EBITDA Growth

    Back to All Ratios
SEQUENT SCIENTIFIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SEQUENT SCIENTIFIC
Please provide your vote to see the results

SEQUENT SCIENTIFIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 143.86294.50-84.74-45.4522.18

What is the latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC ?

The latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC is 143.86 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025143.86
Mar2024294.50
Mar2023-84.74
Mar2022-45.45
Mar202122.18

How is Core EBITDA Growth of SEQUENT SCIENTIFIC Trending?

Years Core EBITDA Growth % Change
Mar2025 143.86
-51.15
Mar2024 294.5
Positive
Mar2023 -84.74
Negative
Mar2022 -45.45
Negative
Mar2021 22.18 -

Other Financial Ratios of SEQUENT SCIENTIFIC


Compare Core EBITDA Growth ratio of peers of SEQUENT SCIENTIFIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC ₹4,646.8 Cr 8% 4.5% 3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹379,191.0 Cr 1% -0.9% -13% Stock Analytics
DIVIS LABORATORIES ₹159,973.0 Cr -1.6% -1.8% 17.9% Stock Analytics
CIPLA ₹124,507.0 Cr -1.8% 3.7% -6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,175.0 Cr 0.7% 2.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,355.0 Cr -0.6% 4.5% -6.5% Stock Analytics


SEQUENT SCIENTIFIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC

8%

4.5%

3.7%

SENSEX

0.5%

0.1%

-2.1%


You may also like the below Video Courses